Helen Kearns v. HHS - Pneumococcal, connective tissue disease (2021)

Helen Kearns filed a petition on May 8, 2018, alleging that the pneumococcal conjugate (Prevnar13) vaccine she received on May 28, 2015, caused her to suffer from connective tissue disease. She further alleged that she suffered residual effects for more than six months.

The respondent denied that the vaccine caused her condition. The parties reached a joint stipulation, which Special Master Christian J.

Moran adopted as the decision of the court. The stipulation awarded Helen Kearns a lump sum payment of $92,500.00, payable to her, as compensation for all damages.

The public decision does not describe the specific onset of symptoms, clinical details, or expert testimony.